Serum HER-2 Levels as a Predictor of Clinical Outcome in Metastatic Breast Cancer (MBC) Patients Treated with Trastuzumab-Based Therapies

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 24; p. iii29
Main Authors Carney, W.P., Thiel, R.
Format Journal Article
LanguageEnglish
Published 01.05.2013
Online AccessGet full text

Cover

Loading…
More Information
ISSN:0923-7534
DOI:10.1093/annonc/mdt084.13